Total Revenue: $32 million, an increase of 84% over Q1 2024. Pro Forma Revenue Growth: 7% increase over pro forma revenue of $29.8 million for Q1 2024. NeuroStar System Revenue: $2.8 million with ...

MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Neuronetics Inc. (STIM) on Tuesday reported a loss of $12.7 million in its first quarter. On a per-share basis, the Malvern, Pennsylvania-based company ...

A "heartbroken" family have told how their 13-year-old boy has ended up stranded in hospital after his arm stopped moving. Kyle Sieniawski, 13, was first admitted in October with problems in one ...

Neuronetics Inc. (STIM) reported its first-quarter 2025 earnings, revealing a net loss of $0.21 per share, missing analyst expectations of a $0.19 loss per share. Despite a robust revenue increase ...

Good day, and thank you for standing by. Welcome to the Neuronetics First Quarter 2025 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode ...

Chief Financial Officer Steve Furlong to retire in March 2026 Significant operational progress with the integration of Greenbrook Projecting cash flow positive in the third quarter of 2025 Major ...

MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Neuronetics Inc. (STIM) on Tuesday reported a loss of $12.7 million in its first quarter. On a per-share basis, the Malvern, Pennsylvania-based company said it ...

U.S. NeuroStar Advanced Therapy System revenue for the three months ended March 31, 2025 was $2.8 million, a decrease of 14% compared to $3.3 million in the first quarter of 2024. For the three months ...